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Abstract 
Objective: To assess the proposed prevalence of unresponsiveness of older men and women 
to augment lean body mass, muscle fiber size, muscle strength, and/or physical function 
following prolonged resistance-type exercise training.   
Design/Setting/Participants: A retrospective analysis of the the adaptive response to 12 (n = 
110) and 24 (n = 85) weeks of supervised resistance-type exercise training in older (>65 y) 
men and women. 
Measurements: Lean body mass (DXA), type I and type II muscle fiber size (biopsy), leg 
strength (1-RM on leg press and leg extension), and physical function (chair rise-time) were 
assessed at baseline, and after 12 and 24 weeks of resistance-type exercise training. 
Results: Lean body mass increased by 0.9±0.1 kg (range: -3.3 to +5.4 kg; P<0.001) from 0-
12 weeks of training. From 0-24 weeks, lean body mass increased by 1.1±0.2 kg (range: -1.8 
to +9.2 kg; P<0.001). Type I and II muscle fiber size increased by 324±137 µm2 (range: -4458 
to +3386 µm2; P=0.021), and 701±137 µm2 (range: -4041 to +3904 µm2; P<0.001) from 0-12 
weeks. From 0-24 weeks, type I and II muscle fiber size increased by 360±157 µm2 (range:    
-3531 to +3426 µm2; P=0.026) and 779±161 µm2 (range: -2728 to +3815 µm2; P<0.001).  
1-RM strength on the leg press and leg extension increased by 33±2 kg (range: -36 to +87 kg; 
P<0.001) and 20±1 kg (range: -22 to +56 kg; P<0.001) from 0-12 weeks. From 0-24 weeks, 
leg press and leg extension 1-RM increased by 50±3 kg (range: -28 to +145 kg; P<0.001) and 
29±1 kg (range: -19 to +60 kg; P<0.001). Chair rise-time decreased by 1.3±0.4 s (range: 
+21.6 to -12.5 s; P=0.003) from 0-12 weeks. From 0-24 weeks, chair rise-time decreased by 
2.3±0.4 s (range: +10.5 to -23.0 s; P<0.001). Non-responsiveness was not apparent in any 
subject, as a positive adaptive response on at least one training outcome was apparent in every 
subject. 
 
 
Conclusions: A large heterogeneity was apparent in the adaptive response to prolonged 
resistance-type exercise training when changes in lean body mass, muscle fiber size, strength, 
and physical function were assessed in older men and women. The level of responsiveness 
was strongly affected by the duration of the exercise intervention, with more positive 
responses following more prolonged exercise training. We conclude that there are no non-
responders to the benefits of resistance-type exercise training on lean body mass, fiber size, 
strength, or function in the older population. Consequently, resistance-type exercise should be 
promoted without restriction to support healthy aging in the older population. 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Introduction 
Ageing is associated with a progressive decline in skeletal muscle mass, strength, and 
physical function, a condition termed sarcopenia1. Sarcopenia is an independent risk factor 
for adverse outcomes including difficulties in carrying out activities of daily living, falls, 
fractures, hospitalization and readmission, and death2. Resistance-type exercise training 
currently represents the primary therapeutic strategy recommended to prevent and reverse the 
age-related decline in skeletal muscle mass, strength, and function3. Current public health 
recommendations for older adults (>65 y) in both Canada and the USA prescribe 150 min of 
moderate- to vigorous-intensity physical activity to be accumulated per week, with additional 
muscle strengthening activities performed twice weekly4, 5. In further support of the benefits 
of resistance-type exercise training in the older population, a recent systematic review of the 
literature confirmed that even the very old (>75 y) retain the capacity for muscle hypertrophy 
and increased strength in response to exercise training6. However, previous work has shown 
substantial inter-individual variability in resistance-type exercise mediated changes in muscle 
mass7-9 and strength8 following a period of standardized exercise training. In response to both 
resistance-8, 9 and endurance-type exercise training10, 11 some individuals seem to demonstrate 
exceptionally large responses, whereas others show only a minimal or even an apparent 
opposite response to prolonged exercise training. Based upon such observations it has been 
suggested that some people may be non-responsive to the benefits of prolonged exercise 
training12-15. However, while some individuals may show no response or even an opposite 
response16 on a single training outcome in response to exercise training, other critically 
important physiological variables may be improved in those individuals after training. 
Therefore, a wide range of response outcomes must be examined in order to fully evaluate the 
efficacy of a resistance training program on participants health17. If a large proportion of the 
older population is indeed unresponsive to the effects of resistance-type exercise training on 
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muscle mass, strength and function, it would be important to identify and possibly even 
characterize these individuals for alternate treatment strategies. Currently, no studies have 
examined the prevalence of unresponsiveness to prolonged resistance-type exercise training 
mediated improvements in lean body mass, muscle fiber size, muscle strength, and physical 
function in the older population. The aim of the present study was to examine the 
responsiveness to prolonged resistance-type exercise on multiple training outcomes including 
lean body mass, muscle fiber size, muscle strength, and physical function following 12 to 24 
weeks of training in a large group older men and women18-20. We hypothesized that despite 
substantial inter-individual variability in the adaptive response to resistance-type exercise 
training, there are no non-responders to the impact of resistance-type exercise training on 
increasing lean body mass, muscle fiber size, strength, or physical function.  
Methods 
Subjects: The subject population included both healthy18, 20, pre-frail and frail older19 men and 
woman (>65 y). Subjects with cancer, chronic obstructive pulmonary disease, muscle disease, 
and those unable to perform exercise due to orthopedic limitations were excluded from the 
study. Subjects with type 2 diabetes (blood glucose >7.0 mmol/L) and renal insufficiency 
(eGFR < 60 mL/min/1.73 m2) were also excluded. All subjects were living independently. 
None of the participants had a history of participating in any structured exercise training 
program designed to improve performance over the past 5 y. All subjects were informed of 
the nature and associated risks of the experimental procedures of each respective study prior 
to obtaining their written informed consent. 
Study design: Subjects participated in either a 1218 or 2419, 20 week program of personally 
supervised resistance-type exercise training. The primary outcome variables in the current 
analysis include lean body mass, type I and type II muscle fiber size, muscle strength, and 
physical function. Lean body mass was assessed by DXA, type I and type II muscle fiber size 
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was assessed by needle biopsy and subsequent immunohistochemistry, muscle strength was 
assessed by evaluation of single repetition maximum (1-RM) in both the leg press and leg 
extension, and physical function was assessed by repeated chair rise-time (sit-to-stand) 
respectively. 
Resistance-type exercise training program: The resistance-type exercise training was carried 
out under supervision of a trained investigator either 219 or 318, 20 times per week and 
performed for 1218 and 2419, 20 weeks, respectively. The 24-week training intervention19, 20 
consisted of evaluation at 12 weeks; this data is included in the present analysis. The details of 
the exercise training programs including the exercise equipment, exercise selection, number 
of sets, number of repetitions, interest rest-intervals, and intensity progression (as a 
percentage of 1-RM maximum) have been described in detail previously18-20. 
Lean body mass, muscle fiber size, maximum strength, and physical function: Lean body mass 
was assessed in the fasted-state via DXA (Lunar Prodigy Advance; GE Health Care, Madison, 
WI) 19 and (Hologic, Discovery A, QDR Series, Bradford, MA) 18, 20. All subjects underwent a 
muscle biopsy from the vastus lateralis 3-d prior to initiating the resistance-type exercise 
training program and 4 d following the 12 and 24 week strength assessments in the overnight 
fasted state. Maximum strength was assessed via evaluation of 1-RM on a leg press and leg-
extension machine (Technogym, Rotterdam, the Netherlands). All 1-RM tests were preceeded 
by a separate familiarization session during which the proper exercise technique was practiced 
and maximum strength was estimated. In a second session, 1-RM strength was determined as 
previously described21. 1-RM testing is preferred to evaluate changes in muscle strength 
during resistance-type exercise training 21. Physical function was assessed via a sit-to-stand 
test. Briefly, for the sit-to-stand test, participants were instructed to fold their arms across their 
chest and stand up/sit down five times, as fast as possible, from a seat at 0.42 m from the 
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floor. Time was recorded from the initial sitting to the final standing position. The fastest out 
of two attempts was used for analysis 22.  
Statistics: The mean, minimum, and maximum values were calculated for the entire subject 
group, and within both men and women, for lean body mass, type I and II muscle fiber size, 
muscle strength (1-RM on both the leg press and leg extension), and physical function (sit-to-
stand test). Differences (absolute changes) from 0-12 weeks and 0-24 weeks for each of the 
above outcome measures were assessed using a one sample t test. Differences (absolute 
changes) between men and women from 0-12 and 0-24 weeks were examined using unpaired 
t tests. Variability was assessed based on the confidence interval (CI) of the mean. Statistical 
analyses were performed using IBM SPSS Statistics (version 20). An α-level of 0.05 was used 
to determine statistical significance.  
Results 
Subjects’ characteristics: Subject characteristics are reported in Table 1. The 12-week 
analysis of lean body mass, 1-RM leg press, and 1-RM leg extension involved 110 subjects, 
while the chair-rise time was completed on 85 subjects. Type I and type II fiber cross-
sectional area data was available for 92 subjects at 12 weeks. The 24-week analysis of lean 
body mass, 1-RM leg press, 1-RM leg extension, and chair rise-time consisted of 85 subjects. 
Type I and type II fiber cross-sectional data was available for 66 subjects at 24 weeks. 
Lean body mass: Prior to training, lean body mass averaged 52.3±1.0 kg (CI: 1.9 kg). Women 
had a lean body mass of 41.8±0.7 kg (CI: 1.5 kg), which was significantly lower (P<0.001) 
compared to men (59.3±0.7 kg; CI: 1.5 kg). Following 12-weeks of training there was a 
significant increase (P<0.001) in lean body mass of 0.9±0.1 kg (CI: 0.2 kg). Men showed a 
0.8±0.1 kg increase (CI: 0.3 kg) while women showed a 1.0±0.2 kg (CI: 0.4 kg) increase 
(Table 2 and 3), with no differences between groups (P=0.50). After 24 weeks of resistance-
type training, the increase in lean body mass averaged 1.1±0.2 kg (P<0.001; CI: 0.4 kg). Men 
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demonstrated a 1.0±0.2 kg (CI: 0.4 kg) increase in lean body mass, while women 
demonstrated a 1.2±0.3 kg (CI: 0.6 kg) increase (P=0.58 between groups). A histogram of 
individual subject changes in lean body mass (absolute changes from baseline) following 12 
and 24 weeks of resistance-type exercise training are shown in Figure 1A and B, respectively. 
Type I and II fiber size: Prior to training, type I and II fiber CSA (µm2) was 5741±147 µm2 
(CI: 293 µm2) and 4540±162 µm2 (CI: 322 µm2) respectively. Men had a type I fiber CSA of 
6136±174 µm2 (CI: 348 µm2) and type II fiber CSA of 5264±166 µm2 (CI: 332 µm2), while 
women had a mean type I fiber CSA of 5063±227 µm2 (CI: 462 µm2), and a type II fiber CSA 
of 3298±209 µm2 (CI: 424 µm2). Pre-training muscle fiber size was significantly lower in 
women in both type I (P<0.001) and type II (P<0.001) fibers. Following 12-weeks of training, 
there was an increase in type I (P=0.021) and type II (P<0.001) fiber CSA of 324±137 µm2 
(CI: 273 µm2), and 701±137 µm2 (CI: 273 µm2) respectively. Men showed an increase of 
451±164 µm2 (CI: 328 µm2) and 1034±172 µm2 (CI: 344 µm2), while women showed an 
increase of 97±244 µm2 (CI: 498 µm2) and 108±191 µm2 (CI: 389 µm2) in type I and II fiber 
size respectively (Table 2 and 3). There was no difference between men and women in the 
change in type I (P=0.22) fiber size from 0-12 weeks, however the change in type II fiber size 
was significantly greater in men compared to women (P<0.001). From 0-24 weeks of training, 
the increase in type I and II fiber size was 360±157 µm2 (P=0.026; CI: 314 µm2), and 
779±161 µm2 (P<0.001; CI: 322 µm2). Men showed an increase of 259±213 µm2 (CI: 432 
µm2) and 946±265 µm2 (CI: 539 µm2) in type I and II fiber size, while women showed an 
increase of 473± 236 µm2 (CI: 481 µm2) and 589±167 µm2 (CI: 342 µm2; Table 2 and 3). 
There were no differences between men and women in the change in type I (P=0.50) or type 
II (P=0.28) fiber size from 0-24 weeks. A histogram of individual subject changes in type I 
and type II fiber size (absolute changes from baseline) following 12 and 24 weeks of 
resistance-type exercise training are shown in Figure 2A and B, and 3A and B respectively. 
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Muscle strength: Baseline 1-RM on the leg press and leg extension was 160±4 kg (CI: 8 kg) 
and 75±2 kg (CI: 4 kg) respectively. Men had a mean 1-RM on the leg press of 183±5 kg (CI: 
9 kg), and leg extension of 86±2 (CI: 4 kg) while women had a mean 1-RM on the leg press 
of 126±4 (CI: 8 kg), and leg extension of 58±2 kg (CI: 4 kg). Men demonstrated significantly 
greater baseline 1-RM strength than women on both the leg press (P<0.001) and leg extension 
(P<0.001). From 0-12-weeks of training, there was an increase in 1-RM strength on the leg 
press and leg extension of 33±2 kg (P<0.001; CI: 4 kg), and 20±1 kg (P<0.001; CI: 2 kg) 
respectively. Men showed an increase of 34±2 kg (CI: 4 kg) and 24±1 kg (CI: 2 kg) while 
women showed an increase of 31±4 kg (CI: 7 kg) and 14±2 kg (CI: 3 kg) on the leg press and 
leg extension respectively (Table 2 and 3). There were no differences between men and 
women on the increase in 1-RM strength on the leg press (P= 0.47), however the increase in 
1-RM strength on the leg extension was significantly greater in men as compared to women 
(P<0.001). From 0-24 weeks, the absolute increase in 1-RM on the leg press and leg 
extension was 50±3 kg (P<0.001; CI: 5 kg), and 29±1 kg (P<0.001; CI: 3 kg). Men showed an 
increase of 53±3 kg (CI: 6 kg) and 36±2 kg (CI: 4 kg), while women showed an increase of 
48±4 kg (CI: 9 kg) and 22±2 kg (CI: 3 kg) on 1-RM strength assessed on the leg press and leg 
extension respectively (Table 2 and 3). There were no differences between men and women 
on the increase in 1-RM strength on the leg press (P=0.32), however the increase in 1-RM 
strength on the leg extension was significantly greater in men as compared to women 
(P<0.001). A histogram of individual subject changes in leg press and leg extension 1-RM 
(absolute change from baseline) following 12 and 24 weeks of resistance-type exercise 
training are shown in Figure 4A and B, and 5A and B respectively. 
Physical function: Prior to training, chair rise-time averaged 11.1±0.6 s (CI: 1.3 s), with men 
having an average of 10.0±0.7 s (CI: 1.4 s) and women having an average of 12.0±1.0 s (CI: 
2.1 s), respectively. There were no differences between men and women in baseline chair rise-
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time (P=0.11). From 0-12-weeks of training, chair rise-time decreased by -1.3±0.4 s 
(P=0.003; CI: 0.8 s), with men and women demonstrating a decrease of -0.6±0.6 s (CI: 1.3 s) 
and -1.9±0.5 s (CI: 1.0 s) respectively (Table 2 and 3). There were no differences between 
men and women in the change in chair rise-time after 12 weeks of resistance-type training 
(P=0.11). After 24 weeks of resistance-type training, the absolute change in chair rise-time 
was -2.3±0.4 seconds (P<0.001; CI: 0.8 s), with men and women demonstrating a decrease of 
-1.2±0.4 s (CI: 0.8) and -3.2±0.7 s (CI: 1.3 s), respectively (Table 2 and 3). The decrease in 
chair rise-time from 0-24 weeks was significantly greater in women as compared to men 
(P=0.01). A histogram of individual subject changes in chair rise-time (absolute changes from 
baseline) following 12 and 24 weeks of resistance-type exercise training are shown in Figure 
6A and B, respectively. 
Discussion 
In the present study, we observed that prolonged (12-24 weeks) resistance-type exercise 
training increased lean body mass, type I and II muscle fiber size, muscle strength, and 
physical function in a large group older men and women, however large inter-individual 
variability in the measured changes in these training outcomes was observed (Fig 1-6). 
Despite the inter-individual variability in the adaptive response to training, we were unable to 
identify a single subject who did not positively respond to resistance-type exercise training. 
All subjects demonstrated increases in at least one of the training outcomes (lean body mass, 
muscle fiber size, strength, and/or physical function) examined. Furthermore, we observed 
that the duration of resistance-type exercise training is an important factor determining an 
individual’s response to exercise training. In other words, there were individuals who 
demonstrated little to no improvements after 12 weeks of training, but showed a substantial 
improvement after 24-weeks of training.  
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Regular resistance-type exercise training has been well-established as an effective 
interventional strategy to increase skeletal muscle mass and strength in both elderly men and 
women20, 23, 24, and has been shown to be accompanied by many favorable consequences on a 
variety of health outcomes25. In the present study we observed increases in lean body mass of 
0.9±0.1 kg (1.8±0.3%) and 1.1±0.2 kg (2.3±0.4%) after 12 and 24 weeks of training, 
respectively. The changes in lean body mass were highly variable between subjects, with 
measured changes ranging from -3.3 (subject #75) to +5.4 kg (subject #63) after 12 weeks, to 
-1.8 (subject #75) and +9.2 kg (subject #69) following 24 weeks of exercise training (Figure 
1A and B). Subject #75, who demonstrated the lowest change in lean body mass in response 
to training at both 12 and 24 weeks, showed positive increases in both type I and II fiber size 
and 1-RM strength, and an improvement in chair rise-time. The precision of DXA for whole-
body lean soft tissue expressed as CV ranges from 0.4-1.3 % (SEM 0.35-0.54 kg) in 
sequential measurements26, and it is difficult to assess whether reported changes on an 
individual level are representative of the actual changes in body mass in the individual. For 
this reason relatively large groups of subjects are generally included to assess the efficacy of a 
given exercise intervention to increase lean body mass8. However, the present analyses 
revealed that 23 subjects (~21%) and 16 subjects (~19%) failed to show a measurable increase 
in lean body mass before and after 12 and 24 weeks of resistance-type exercise training 
(Figure 1A and B). Despite 23 subjects not demonstrating a measurable increase in lean body 
mass from 0-12 weeks, 9 of these subjects (subject #: 36, 38, 18, 9, 82, 74, 79, 28, 6) 
demonstrated a positive increase in lean body mass from 0-24 weeks (Figure 1A and B). 
In agreement with previous studies demonstrating that even the very old maintain the 
capacity to augment muscle fiber size in response to resistance-type exercise training27, 28, 
type I fiber CSA increased by 8±3% and 9±3% following 12 and 24 weeks of resistance-type 
training, respectively. Similarly, type II fiber CSA increased by 17±3% and 23±4% following 
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12 and 24 weeks of training. Despite such large average increases in type I and II fiber size, 
there was substantial heterogeneity in the individual changes. For example, changes in type I 
and II muscle fiber size ranged from -4458 (subject #53) and -4041 (subject #55) µm2 to 
+3386 (subject #55) and +3904 (subject #88) µm2 from 0-12 weeks of training (Figure 2A and 
3A; Table 2 and 3). Similar observations of inter-individual variability were observed from 0-
24 weeks of training (Figure 2B and 3B; Table 2 and 3). The present analyses revealed that 36 
subjects (~39%) and 22 subjects (~33%) did not show an increase in type I muscle fiber size, 
while we failed to detect a measurable increase in type II muscle fiber size in 25 subjects 
(~27%) and 17 subjects (~26%) following 12 and 24 weeks of training (Figures 2-3). Despite 
the relatively large number of subjects who did not show measurable increases in muscle fiber 
size, every one of these subjects demonstrated substantial increases in 1-RM leg strength, 
possibly implying improved neurological function in response to training29.  
Consistent with previous work18-20, resistance-type exercise training resulted in 
substantial increases in muscle strength (Figure 4 and 5). Leg press 1-RM increased by 23±2 
and 35±2% following 12 and 24 weeks of training. Similar observations were observed for the 
leg extension (28±2 and 42±2%, respectively). Although there was substantial inter-individual 
variability in the changes in 1-RM leg strength, only 2 subjects failed to demonstrate 
measurable increases in 1-RM leg press (subject #85 and #26) and leg extension (subject #85 
and #79) strength after 12 weeks of training. Similarly, only a single subject (subject #85) did 
not show an increase in leg strength after 24 weeks of training. Of interest, this subject (#85) 
demonstrated the greatest improvements in chair rise-time ability at both 12 and 24 weeks 
post-training. Substantial improvements in physical function were also observed, with a large 
8.2±2.5 and 17.8±2.0% reduction in the time required for the chair rise test following 12 and 
24 weeks of training. Twenty subjects (20%) failed to show improvement on the chair rise-
time test after 12 weeks of training. After 24 weeks, only 5 subjects (6%) showed no 
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improvement compared to baseline values (Figure 6). This observation demonstrates that 
being non-responsive after 12 weeks of training certainly is not predictive on the outcome 
after a more prolonged training intervention.  
In the present study, we present the individual changes in lean body mass, type I and II 
muscle fiber size, leg strength, and functional capacity in a large group of older men and 
women. There was quite some variance in the changes in lean body mass, muscle fiber size, 
strength, and function between individuals. This is in line with the established heterogeneity 
in the adaptive response to training7-9 and this may be further augmented by the differences 
between subjects regarding the level of frailty, nutritional status, protein supplementation, and 
training regimen within the included cohorts18-20, 30. Some individuals seemed to show no or 
even an apparent negative response on one of the outcome parameter (Figures 1-6) and could, 
therefore, be referred to as “non-responders”9 or “adverse responders”16. However, a critical 
evaluation of the individual data demonstrates that subjects who seemed unresponsive in 
regard to, for example, an increase in lean body mass after 12 (subject #74, 94, 5, 61, 85, 2, 
36, 88, 3, 56, 70, 109, 38, 18, 108, 9, 53, 82, 74, 55, 79, 28, 6) or 24 (subject #75, 5, 53, 2, 57, 
61, 11, 55, 70, 3, 81, 85, 56, 17, 77, 66) weeks of exercise training, were all highly responsive 
to one or more of the other training outcomes. In fact, only 2 out of 110 subjects (<1%) failed 
to show improvements in 1-RM leg strength after 12 weeks of training. Our findings appear to 
agree with the suggestion that the inter-correlation between being unresponsive to training on 
one physiological trait and another is very low (~r = 0.1-0.05)15. Thus, lack of improvement 
on one specific phenotype (i.e. lean body mass or muscle fiber size) is not a reason not to 
recommend or prescribe resistance-type exercise training because substantial improvements in 
another phenotype (strength and/or physical function) can still be obtained. Furthermore, there 
was a decline in the number of people deemed unresponsive when comparing responses 
following 12 and 24 weeks of training. In other words, being non-responsive to the impact of 
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12 weeks of exercise training on a certain parameter does not preclude a normal adaptive 
response observed after more prolonged intervention. Consequently, our data do not provide 
any sign of the existence of non-responsiveness to the benefits of resistance-type exercise 
training. Moreover, we feel it is a misconception to assume that a few single measurements in 
time provide realistic insight in the absolute changes in a certain physiological trait within a 
single individual. There is a reason why groups of subjects are included in clinical studies and 
why statistical tests are used to test research hypotheses. The present data set shows that 
conclusions based on an n=1 can be quite deceiving. The important work of many of our 
colleagues addressing the basis of the observed heterogeneity in the adaptive response to 
exercise interventions7-10, 12, 31-33 is often misinterpreted by the popular media suggesting that a 
substantial part of the population does not benefit from an exercise intervention.  
Conclusions 
The present data show that there is no rationale to assume that there is such a thing as 
unresponsiveness to the benefits of exercise training and, as such, we should not be restrictive 
in the prescription of resistance-type exercise training to augment lean body mass, muscle 
fiber size, muscle strength, and physical function in the older population. Even in situations 
where an individual demonstrates what might be classified as an adverse response to 
exercise16 on a single outcome measure, that response needs to be carefully weighed against 
the myriad of health benefits derived from regular exercise training. Of course, we can only 
speculate on the relative contribution of musculo-skeletal, neurological or behavioral 
adaptation on the reported increases in muscle mass, strength and function in the older 
population. In conclusion, there are no non-responders to the benefits of resistance-type 
exercise training on lean body mass, muscle fiber size, muscle strength, or function in the 
older population. Resistance-type exercise should be promoted to support healthy aging in the 
older population. 
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Figure legends 
Figure 1. Histogram of the absolute changes in lean body mass (kg) for each individual 
subject following 12 (A) and 24 (B) weeks of resistance-type exercise training in elderly men 
and women. Numbers next to the bars represent the individual subjects and match with the 
same subject number presented in Figures 1-6.  
Figure 2. Histogram of the absolute changes in type I muscle fiber cross-sectional area (µm2) 
for each individual subject following 12 (A) and 24 (B) weeks of resistance-type exercise 
training in elderly men and women. Numbers next to the bars represent the individual subjects 
and match with the same subject number presented in Figures 1-6. 
Figure 3. Histogram of the absolute changes in type II muscle fiber cross-sectional area (µm2) 
for each individual subject following 12 (A) and 24 (B) weeks of resistance-type exercise 
training in elderly men and women. Numbers next to the bars represent the individual subjects 
and match with the same subject number presented in Figures 1-6. 
Figure 4. Histogram of the absolute changes in 1-RM on the leg press (kg) for each individual 
subject following 12 (A) and 24 (B) weeks of resistance-type exercise training in elderly men 
and women. Numbers next to the bars represent the individual subjects and match with the 
same subject number presented in Figures 1-6. 
Figure 5. Histogram of the absolute changes in 1-RM on the leg extension (kg) for each 
individual subject following 12 (A) and 24 (B) weeks of resistance-type exercise training in 
elderly men and women. Numbers next to the bars represent the individual subjects and match 
with the same subject number presented in Figures 1-6. 
Figure 6. Histogram of the absolute changes in chair rise-time (seconds) for each individual 
subject following 12 (A) and 24 (B) weeks of resistance-type exercise training in elderly men 
and women. Numbers next to the bars represent the individual subjects and match with the 
same subject number presented in Figures 1-6.
 
 
 
TABLE 1. Subjects’ characteristics 
Group Age (y) Height (m) Bodyweight 
(kg) 
BMI 
12 week analysis     
All (n=110) 72.6 ± 0.6 1.70 ± 0.01 78.1 ± 1.1 27.1 ± 0.4 
Men (n=66) 72.6 ± 0.9 1.74 ± 0.01 82.9 ± 1.4 27.2 ± 0.4 
Women (n = 44) 72.6 ± 0.9 1.62 ± 0.01 71.0 ± 1.8 26.9 ± 0.7 
24 week analysis     
All (n = 85) 72.8 ± 0.8 1.69 ± 0.01 77.7 ± 1.5 27.2 ± 0.4 
Men (n = 41) 73.0 ± 1.2 1.76 ± 0.01 84.8 ± 1.7 27.4 ± 0.5 
Women (n = 44) 72.6 ± 0.9 1.62 ± 0.01 71.0 ± 1.8 26.9 ± 0.7 
Data represent means±SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 2. Absolute changes in lean body mass, type I and II muscle fiber size, leg strength, and 
functional function. 
Absolute change from baseline 
Variable 12-weeks Min  
12-weeks 
Max  
12-weeks 
24-weeks Min  
24-weeks 
Max  
24-weeks 
 
Lean body mass (kg)       
All 0.9 ± 0.1   1.1 ± 0.2   
Men 0.8 ± 0.1 -3.3 +3.4 1.0 ± 0.2 -1.8 +3.8 
Women 1.0 ± 0.2 -1.2 +5.4 1.2 ± 0.3 -1.5 +9.2 
Type I fiber size (µm2)       
All 324 ± 137   360 ± 157   
Men 451 ± 164 -1694 +3170 259 ± 213 -3509 +2249 
Women 97 ± 244 -4458 +3386 473 ± 236 -3531 +3426 
Type II fiber size (µm2)       
All 701 ± 137   779 ± 161   
Men 1034 ± 172 -3212 +3904 946 ± 265 -2728 +3815 
Women 108 ± 191 -4041 +2010 589 ± 167 -1737 +1896 
1-RM leg press (kg)       
All 33 ± 2   50 ± 3   
Men 34 ± 2 +10 +75 53 ± 3 +24 +115 
Women 31 ± 4 -36 +87 48 ± 5 -28 +145 
1-RM leg ext (kg)       
All 20 ± 1   29 ± 2   
Men 24 ± 1 0 +56 26 ± 2 +2 +57 
Women 14 ± 2 -22 +45 22 ± 2 -19 +60 
Chair rise-time (s)       
All -1.3 ± 0.4   -2.3 ± 0.4   
Men -0.6 ± 0.6 +21.6 -6.0 -1.2 ± 0.4 +10.5 -6.3 
Women -1.9 ± 0.5 +3.1 -12.5 -3.2 ± 0.7 +2.3 -23.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 3. Percent changes in lean body mass, type I and II muscle fiber size, leg strength, and 
functional function. 
Percent (%) change from baseline 
Variable 12-weeks Min  
12-weeks 
Max  
12-weeks 
24-weeks Min  
24-weeks 
Max  
24-weeks 
 
Lean body mass (%)       
All 1.8 ± 0.3   2.3 ± 0.4   
Men 1.4 ± 0.3 -5.7 +6.7 1.6 ± 0.3 -3.1 +5.7 
Women 2.4 ± 0.5 -3.3 +13.2 2.8 ± 0.6 -3.5 +19.0 
Type I fiber size (%)       
All 8 ± 3   9 ± 3   
Men 9 ± 3 -28 +74 7 ± 4 -43 +51 
Women 6 ± 5 -54 +92 11 ± 5 -56 +69 
Type II fiber size (%)       
All 17 ± 3   23 ± 4   
Men 20 ± 3 -39 +74 21 ± 6 -51 +104 
Women 12 ± 5 -50 +74 24 ± 6 -37 +78 
1-RM leg press (%)       
All 23 ± 2   35 ± 2   
Men 20 ± 1 +3 +50 29 ± 2 +13 +85 
Women 27 ± 4 -37 +106 40 ± 4 -29 +126 
1-RM leg ext (%)       
All 28 ± 2   42 ± 2   
Men 29 ± 2 0 +75 44 ± 3 +3 +91 
Women 26 ± 4 -45 +108 41 ± 4 -39 +113 
Chair rise-time (%)       
All -8.2 ± 2.5   -17.8 ± 1.9   
Men -5.3 ± 4.3 +140.8 -30.4 -13.8 ± 3.0 +52.6 -42.9 
Women -10.9 ± 2.7 +40.3 -53.9 -21.5 ± 2.4 +18.0 -54.0 
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Figure 6 
 
-25 -20 -15 -10 -5 0 5 10 15 20 25
85
69
54
53
64
65
82
57
55
60
76
80
75
72
81
33
61
50
41
11
37
51
39
68
78
52
48
30
47
58
24
23
67
1
38
31
5
28
32
21
43
26
9
45
18
36
70
12
16
13
29
3
22
27
7
14
4
20
6
19
34
46
25
2
66
49
35
8
42
71
77
74
44
15
17
56
73
40
84
10
63
79
62
59
83
0-12 weeks
Delta chair rise-time (s)
-25 -20 -15 -10 -5 0 5 10 15 20 25
85
54
69
53
80
81
55
60
64
82
76
57
51
58
70
23
66
63
78
37
11
38
62
50
5
47
14
52
24
75
73
12
68
48
13
32
43
1
39
41
61
16
67
4
30
36
6
56
33
18
20
84
21
2
9
46
8
15
22
45
28
49
44
3
35
34
7
29
31
40
71
77
19
17
42
27
72
26
10
25
59
74
83
79
65
0-24 weeks
Delta chair rise-time (s)
 
 
 
